The company had announced the expected date of completion of sale and disposal of the said undertaking is 90 days from the date of signing the Definitive Agreements.
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
Subscribe To Our Newsletter & Stay Updated
